Dietary Intake of Coenzyme Q10 Reduces Oxidative Stress in Patients With Acute Ischemic Stroke: A Double-Blind, Randomized Placebo-Controlled Study Publisher Pubmed



Mojaver A¹ ; Khazaei M² ; Ahmadpanah M³ ; Zarei M⁴ ; Soleimani Asl S⁵ ; Habibi P⁶ ; Shahidi S⁷ Show Affiliations
Source: Neurological Research Published:2025

Abstract

Objectives: Ischemic stroke is one of the most common neurological disorders. Oxidative stress, inflammation, and the reduction of Brain-Derived Neurotrophic Factor (BDNF) are implicated in cell death during ischemic stroke. Several studies suggest that Coenzyme Q10 (CoQ10) has antioxidant, anti-inflammatory, neuroprotective properties and can increase BDNF levels. This study investigated the effects of oral CoQ10 supplementation on oxidative stress biomarkers Total Antioxidant Capacity (TAC), Superoxide Dismutase (SOD), Malondialdehyde (MDA), Total Thiol Groups (TTG)–as well as serum levels of Interleukin-6 (IL-6) and BDNF in ischemic stroke patients. Methods: Fifty patients hospitalized for acute ischemic stroke were randomly divided into two groups: placebo (n = 25) and CoQ10 (600 mg/day) supplementation (n = 25). The intervention began 24 hours after stroke onset and continued for 30 days. Results: Significant reductions in serum MDA and IL-6 levels, alongside increased SOD and BDNF levels, were observed in the CoQ10 group. No significant differences were found in TAC or TTG levels between the groups. Conclusions: A 30-day regimen of CoQ10 (600 mg/day) resulted in reduced oxidative stress and inflammation, alongside increased BDNF, suggesting potential neuroprotective benefits for post-stroke rehabilitation. CoQ10 May be considered a therapeutic option for enhancing neuroprotection and rehabilitation in stroke patients. © 2025 Informa UK Limited, trading as Taylor & Francis Group.